PDF(Pubmed)
Abstract：
The negative effects of loneliness on population health and wellbeing requires interventions that transcend the medical system and leverage social, cultural, and public health system resources. Group-based social interventions are a potential method to alleviate loneliness. Moreover, nature, as part of our social and health infrastructure, may be an important part of the solutions that are needed to address loneliness. The RECETAS European project H2020 (Re-imagining Environments for Connection and Engagement: Testing Actions for Social Prescribing in Natural Spaces) is an international research project aiming to develop and test the effectiveness of nature-based social interventions to reduce loneliness and increase health-related quality of life.
This article describes the three related randomized controlled trials (RCTs) that will be implemented: the RECETAS-BCN Trial in Barcelona (Spain) is targeting people 18+ from low socio-economic urban areas; the RECETAS-PRG Trial in Prague (Czech Republic) is addressing community-dwelling older adults over 60 years of age, and the RECETAS-HLSNK trial is reaching older people in assisted living facilities. Each trial will recruit 316 adults suffering from loneliness at least sometimes and randomize them to nature-based social interventions called \"Friends in Nature\" or to the control group. \"Friends in Nature\" uses modifications of the \"Circle of Friends\" methodology based on group processes of peer support and empowerment but including activities in nature. Participants will be assessed at baseline, at post-intervention (3 months), and at 6- and 12-month follow-up after baseline. Primary outcomes are the health-related quality-of-life according to 15D measure and The De Jong Gierveld 11-item loneliness scale. Secondary outcomes are health and psychosocial variables tailored to the specific target population. Nature exposure will be collected throughout the intervention period. Process evaluation will explore context, implementation, and mechanism of impact. Additionally, health economic evaluations will be performed.
The three RECETAS trials will explore the effectiveness of nature-based social interventions among lonely people from various ages, social, economic, and cultural backgrounds. RECETAS meets the growing need of solid evidence for programs addressing loneliness by harnessing the beneficial impact of nature on enhancing wellbeing and social connections.
Barcelona (Spain) trial: ClinicalTrials.gov, ID: NCT05488496. Registered 29 July 2022. Prague (Czech Republic) trial: ClinicalTrials.gov, ID: NCT05522140. Registered August 25, 2022. Helsinki (Finland) trial: ClinicalTrials.gov, ID: NCT05507684. Registered August 12, 2022.
This article describes the three related randomized controlled trials (RCTs) that will be implemented: the RECETAS-BCN Trial in Barcelona (Spain) is targeting people 18+ from low socio-economic urban areas; the RECETAS-PRG Trial in Prague (Czech Republic) is addressing community-dwelling older adults over 60 years of age, and the RECETAS-HLSNK trial is reaching older people in assisted living facilities. Each trial will recruit 316 adults suffering from loneliness at least sometimes and randomize them to nature-based social interventions called \"Friends in Nature\" or to the control group. \"Friends in Nature\" uses modifications of the \"Circle of Friends\" methodology based on group processes of peer support and empowerment but including activities in nature. Participants will be assessed at baseline, at post-intervention (3 months), and at 6- and 12-month follow-up after baseline. Primary outcomes are the health-related quality-of-life according to 15D measure and The De Jong Gierveld 11-item loneliness scale. Secondary outcomes are health and psychosocial variables tailored to the specific target population. Nature exposure will be collected throughout the intervention period. Process evaluation will explore context, implementation, and mechanism of impact. Additionally, health economic evaluations will be performed.
The three RECETAS trials will explore the effectiveness of nature-based social interventions among lonely people from various ages, social, economic, and cultural backgrounds. RECETAS meets the growing need of solid evidence for programs addressing loneliness by harnessing the beneficial impact of nature on enhancing wellbeing and social connections.
Barcelona (Spain) trial: ClinicalTrials.gov, ID: NCT05488496. Registered 29 July 2022. Prague (Czech Republic) trial: ClinicalTrials.gov, ID: NCT05522140. Registered August 25, 2022. Helsinki (Finland) trial: ClinicalTrials.gov, ID: NCT05507684. Registered August 12, 2022.
摘要：
背景：孤独感对人口健康和福祉的负面影响需要超越医疗系统并利用社会，文化,和公共卫生系统资源。基于群体的社会干预是缓解孤独感的一种潜在方法。此外，自然,作为我们社会和卫生基础设施的一部分，可能是解决孤独所需的解决方案的重要组成部分。RECETAS欧洲项目H2020（重新想象联系和参与的环境：在自然空间中进行社会处方的测试行动）是一个国际研究项目，旨在开发和测试基于自然的社会干预措施的有效性，以减少孤独和提高健康相关的生活质量。
方法：本文介绍了将实施的三项相关随机对照试验（RCT）：巴塞罗那（西班牙）的RECETAS-BCN试验针对的是来自低社会经济城市地区的18岁以上人群；布拉格（捷克共和国）的RECETAS-PRG试验针对的是60岁以上的社区居住老年人，RECETAS-HLSNK试验正在辅助生活设施中覆盖老年人.每个试验将招募316名患有孤独感的成年人，并将他们随机分配到基于自然的社会干预措施中，称为“自然之友”或对照组。“自然之友”使用“朋友圈”方法的修改，该方法基于同伴支持和授权的小组过程，但包括自然活动。参与者将在基线进行评估，在干预后（3个月），以及基线后6个月和12个月的随访。根据15D测量和DeJongGierveld11项孤独感量表，主要结果是与健康相关的生活质量。次要结果是针对特定目标人群的健康和社会心理变量。将在整个干预期间收集自然暴露。过程评估将探索背景，实施，和影响机制。此外,将进行卫生经济评估。
结论：三项RECETAS试验将探讨基于自然的社会干预措施在不同年龄的孤独人群中的有效性，社会,经济,和文化背景。RECETAS通过利用自然对增进福祉和社会关系的有益影响来满足解决孤独感的计划日益增长的确凿证据需求。
背景：巴塞罗那（西班牙）试验：ClinicalTrials.gov，ID:NCT05488496。2022年7月29日注册。布拉格（捷克共和国）审判：ClinicalTrials.gov，ID:NCT05522140。2022年8月25日注册。赫尔辛基（芬兰）试验：ClinicalTrials.gov，ID:NCT05507684。2022年8月12日注册。
方法：本文介绍了将实施的三项相关随机对照试验（RCT）：巴塞罗那（西班牙）的RECETAS-BCN试验针对的是来自低社会经济城市地区的18岁以上人群；布拉格（捷克共和国）的RECETAS-PRG试验针对的是60岁以上的社区居住老年人，RECETAS-HLSNK试验正在辅助生活设施中覆盖老年人.每个试验将招募316名患有孤独感的成年人，并将他们随机分配到基于自然的社会干预措施中，称为“自然之友”或对照组。“自然之友”使用“朋友圈”方法的修改，该方法基于同伴支持和授权的小组过程，但包括自然活动。参与者将在基线进行评估，在干预后（3个月），以及基线后6个月和12个月的随访。根据15D测量和DeJongGierveld11项孤独感量表，主要结果是与健康相关的生活质量。次要结果是针对特定目标人群的健康和社会心理变量。将在整个干预期间收集自然暴露。过程评估将探索背景，实施，和影响机制。此外,将进行卫生经济评估。
结论：三项RECETAS试验将探讨基于自然的社会干预措施在不同年龄的孤独人群中的有效性，社会,经济,和文化背景。RECETAS通过利用自然对增进福祉和社会关系的有益影响来满足解决孤独感的计划日益增长的确凿证据需求。
背景：巴塞罗那（西班牙）试验：ClinicalTrials.gov，ID:NCT05488496。2022年7月29日注册。布拉格（捷克共和国）审判：ClinicalTrials.gov，ID:NCT05522140。2022年8月25日注册。赫尔辛基（芬兰）试验：ClinicalTrials.gov，ID:NCT05507684。2022年8月12日注册。
